Keiretsu Capital

Healionics Corporation, founded in 2007 and based in Seattle, Washington, specializes in the development and manufacturing of synthetic biomaterials and implantable medical devices aimed at improving healthcare for kidney failure patients. The company has created STARport HD, an implantable device that enables needle-free access to the bloodstream for hemodialysis, and STARgraft, a synthetic vascular graft designed to maintain long-term blood flow without frequent interventions. Healionics' innovations address critical challenges in dialysis treatment, particularly the unreliability of current vascular access methods, which can lead to costly complications. Their STAR biomaterial technology enhances the performance of medical implants by reducing infection and scar tissue formation. Healionics is preparing to initiate human studies for its products, with a focus on improving patient outcomes and reducing overall treatment costs in the dialysis sector.

Kineta, Inc. is a clinical stage biotechnology company based in Seattle, Washington, focused on the development of immunology-based therapeutics for oncology, neuroscience, and virology. The company is advancing a range of innovative therapies, including KCP-506, a non-opioid antagonist for chronic pain, and LHF-535, an oral antiviral targeting Lassa and other arenaviruses by inhibiting viral entry and replication. Kineta is also engaged in developing next-generation immunotherapies, exemplified by KVA12.1, a VISTA blocking immunotherapy designed to reprogram the immune system to combat cancer. With strategic partnerships with notable organizations like Pfizer and Genentech, Kineta aims to leverage its expertise in antiviral therapies and immune modulation to address significant medical challenges. Formerly known as Lecura, Inc., the company was founded in 2007.

Votegrity is a Seattle-based company founded in 2020 that provides online election services designed to enhance voter accessibility and confidence in the electoral process. Its platform employs end-to-end verification and cryptographic technology to ensure that each ballot is counted as intended while protecting voter privacy. By allowing voters to cast their votes from computers or smart devices, Votegrity aims to create a more informed electorate and streamline the voting experience. Additionally, the platform contributes to environmental sustainability by reducing paper usage associated with traditional voting methods.

ActX, Inc. is a company based in Seattle, Washington, founded in 2012, that specializes in integrating genomic information into clinical practice. The company focuses on providing actionable clinical insights derived from patients' genetic data, which helps healthcare providers personalize medical care. ActX offers services that include the collection and analysis of saliva samples, ensuring that genetic information is securely stored and privately managed. This enables physicians to access relevant genomic insights either through electronic medical records or a secure online platform, thereby enhancing patient care and improving health outcomes.

Loopr AI, founded in 2021 and based in Bellevue, Washington, offers a no-code artificial intelligence platform aimed at streamlining business automation for organizations of various sizes. The platform allows businesses to implement pre-built AI solutions quickly, often within hours or days, facilitating the resolution of complex challenges through AI-driven processes and advanced machine learning techniques. By leveraging Loopr AI's tools, organizations can enhance quality, reduce operational costs, and automate a wide range of processes across different industries and functions.

React Mobile, Inc. is a Seattle-based company that develops a personal safety smartphone application tailored for the hospitality industry and other sectors such as healthcare, transportation, education, and logistics. The application includes features like Follow-Me, which allows users to share their real-time location with friends and family, and The React Sidekick, a personal panic button that connects users to a network in emergencies. The platform is designed to enhance workplace safety by enabling quick response times; in the event of an alert, it sends notifications with GPS coordinates to emergency contacts via text and email, facilitating rapid assistance. React Mobile's offerings are especially relevant in the context of workplace safety regulations, such as those mandating panic buttons for hotel workers in Seattle. Founded in 2011, the company's focus is on ensuring employee safety and efficient emergency response.

Votegrity is a Seattle-based company founded in 2020 that provides online election services designed to enhance voter accessibility and confidence in the electoral process. Its platform employs end-to-end verification and cryptographic technology to ensure that each ballot is counted as intended while protecting voter privacy. By allowing voters to cast their votes from computers or smart devices, Votegrity aims to create a more informed electorate and streamline the voting experience. Additionally, the platform contributes to environmental sustainability by reducing paper usage associated with traditional voting methods.

Inmedix, LLC is a company focused on developing diagnostics and therapeutics for autoimmune diseases by assessing and optimizing the autonomic nervous system's (ANS) control of stress responses in the brain. Founded in 2006 and located in Normandy Park, Washington, Inmedix has introduced a novel class of diagnostics and therapeutics aimed at understanding the relationship between ANS stress and autoimmune conditions. This approach, termed Immuno-autonomics, seeks to mitigate the exacerbating effects of stress on autoimmune diseases, enhancing the efficacy of existing therapies. Inmedix offers a cloud-based software platform along with diagnostic devices that track the interaction between stress and immune function, providing valuable insights for clinicians and opportunities in drug discovery.

ActX, Inc. is a company based in Seattle, Washington, founded in 2012, that specializes in integrating genomic information into clinical practice. The company focuses on providing actionable clinical insights derived from patients' genetic data, which helps healthcare providers personalize medical care. ActX offers services that include the collection and analysis of saliva samples, ensuring that genetic information is securely stored and privately managed. This enables physicians to access relevant genomic insights either through electronic medical records or a secure online platform, thereby enhancing patient care and improving health outcomes.

LumiThera, Inc. is a medical device company dedicated to developing innovative treatment solutions aimed at improving visual function and preventing vision loss associated with debilitating eye diseases. Founded in 2013 and based in Poulsbo, Washington, the company specializes in photobiomodulation therapy, utilizing non-invasive light-emitting diodes (LEDs) and laser treatments to address both acute and chronic ocular disorders. Its flagship product, The Valeda, is designed specifically for the treatment of dry age-related macular degeneration (AMD) and other ocular conditions. LumiThera's technology not only strives to halt or slow the progression of vision-threatening diseases but also aims to enhance visual acuity and contrast sensitivity in patients. Through its advancements in light therapy, LumiThera supports healthcare providers in offering improved treatment options for individuals affected by these common eye disorders.

KitoTech Medical is a medical device company based in Seattle, Washington, focused on developing and commercializing innovative products for wound closure and care. The company's flagship product, microMend, features a unique design that incorporates tiny Microstaples on an adhesive backing, resembling a butterfly bandage. This product is painless to apply and offers the holding strength of traditional sutures, making it suitable for closing surgical incisions and lacerations. Clinical studies indicate that microMend outperforms sutures in various clinical outcomes, including cosmetic results, and can be applied more quickly by a range of medical personnel, resulting in significant cost savings. microMend is marketed across numerous surgical specialties, as well as in dermatology and emergency medicine, with additional commercialization efforts targeting military applications. The potential market for microMend is substantial, estimated at over $600 million in the U.S. and around $2 billion globally. KitoTech Medical was founded in 2011.

Pathware Inc. specializes in developing automated point-of-care biopsy assessment systems aimed at enhancing the diagnostic capabilities of clinicians and pathologists. Its flagship product, Bioptic, allows for the rapid diagnosis of pathogens, while its sample management platform streamlines the pathology workflow by minimizing repetitive tasks. The company’s digital pathology platform integrates advanced hardware and software tools, facilitating immediate analysis of tissue samples at the point of care, thereby reducing the need to send samples to central laboratories. This innovation significantly shortens turnaround times and improves patient care through AI-powered image analysis and telepathology capabilities. Founded in 2017 and headquartered in Ann Arbor, Michigan, with an additional location in Seattle, Washington, Pathware is dedicated to improving healthcare by leveraging computational microscopy and artificial intelligence for more accurate and timely disease diagnosis and treatment.

HaptX develops advanced virtual reality gloves that simulate touch sensation with remarkable realism. By utilizing patented microfluidic technology, HaptX Gloves offer 130 points of touch feedback and provide resistive force feedback of 4 lbs. per finger while tracking hand motions with sub-millimeter precision. This innovative device creates a haptic experience that allows users to perceive the texture, shape, motion, vibration, and temperature of virtual objects, enhancing interaction within the virtual environment. Founded by Jake Rubin and Dr. Bob Crockett, HaptX operates with a team of 35 employees across offices in Seattle, Washington, and San Luis Obispo, California.

Joule Case, Inc. designs and manufactures innovative battery and solar modules, providing scalable energy solutions that prioritize mobility and sustainability. Founded in 2015 and based in Seattle, Washington, the company offers a range of products, including various control and battery modules, which cater to diverse applications such as live events, electric vehicle fleet extension, construction sites, and portable food and beverage services. Joule Case's systems are engineered to integrate seamlessly with renewable energy sources, enabling users to minimize emissions and overcome traditional energy infrastructure limitations. The company's offerings promote a quieter, more efficient alternative to conventional gas generators while enhancing energy storage capabilities and adaptability to specific power needs.

Pattern Computer, Inc. is a pattern discovery company based in Friday Harbor, Washington, that specializes in uncovering insights from complex datasets. Founded in 2016, the company has developed a proprietary system that generates hypotheses and insights, enabling clients to tackle challenging problems in fields such as medical research and business analytics. Its platform is particularly noted for its application in breast cancer prognostics and the differentiation of healthy and disease-state pathways in microbiome and human gut disorders. By utilizing advanced techniques that surpass conventional methods, Pattern Computer aims to reveal novel patterns that can drive innovation and improve industry standards.

Healionics Corporation, founded in 2007 and based in Seattle, Washington, specializes in the development and manufacturing of synthetic biomaterials and implantable medical devices aimed at improving healthcare for kidney failure patients. The company has created STARport HD, an implantable device that enables needle-free access to the bloodstream for hemodialysis, and STARgraft, a synthetic vascular graft designed to maintain long-term blood flow without frequent interventions. Healionics' innovations address critical challenges in dialysis treatment, particularly the unreliability of current vascular access methods, which can lead to costly complications. Their STAR biomaterial technology enhances the performance of medical implants by reducing infection and scar tissue formation. Healionics is preparing to initiate human studies for its products, with a focus on improving patient outcomes and reducing overall treatment costs in the dialysis sector.

Tilting Motor Works, Inc. specializes in developing leaning three-wheel conversion solutions for motorcycles, enhancing their stability and safety without compromising performance. Founded in 2008 and headquartered in Snohomish, Washington, the company replaces the front fork and wheel of traditional motorcycles with a new front end that integrates various components, including shocks, wheels, tires, brakes, and hydraulic systems. This patented retrofit aims to provide riders with an improved riding experience by offering higher performance and increased confidence on the road. With a focus on safety and stability, Tilting Motor Works continues to innovate in the motorcycle modification industry.

Inmedix, LLC is a company focused on developing diagnostics and therapeutics for autoimmune diseases by assessing and optimizing the autonomic nervous system's (ANS) control of stress responses in the brain. Founded in 2006 and located in Normandy Park, Washington, Inmedix has introduced a novel class of diagnostics and therapeutics aimed at understanding the relationship between ANS stress and autoimmune conditions. This approach, termed Immuno-autonomics, seeks to mitigate the exacerbating effects of stress on autoimmune diseases, enhancing the efficacy of existing therapies. Inmedix offers a cloud-based software platform along with diagnostic devices that track the interaction between stress and immune function, providing valuable insights for clinicians and opportunities in drug discovery.

Healionics Corporation, founded in 2007 and based in Seattle, Washington, specializes in the development and manufacturing of synthetic biomaterials and implantable medical devices aimed at improving healthcare for kidney failure patients. The company has created STARport HD, an implantable device that enables needle-free access to the bloodstream for hemodialysis, and STARgraft, a synthetic vascular graft designed to maintain long-term blood flow without frequent interventions. Healionics' innovations address critical challenges in dialysis treatment, particularly the unreliability of current vascular access methods, which can lead to costly complications. Their STAR biomaterial technology enhances the performance of medical implants by reducing infection and scar tissue formation. Healionics is preparing to initiate human studies for its products, with a focus on improving patient outcomes and reducing overall treatment costs in the dialysis sector.

OtoNexus Medical Technologies Inc. specializes in the design, development, and commercialization of a patented ultrasound medical device aimed at diagnosing middle ear infections, also known as otitis media, in both children and adults. This innovative device provides clinicians with the ability to differentiate between viral and bacterial infections, facilitating informed decisions regarding the necessity of antibiotics. By employing ultrasound technology in a novel manner, the device delivers rapid diagnosis in seconds and can be utilized by various healthcare professionals, including physicians and non-physician personnel. Additionally, the incorporation of one-use-per-patient tips generates a recurring revenue stream for the company. Founded in 2010 and based in Seattle, Washington, OtoNexus Medical Technologies was previously known as OtoMetrix Medical Technologies before rebranding in July 2014.

KitoTech Medical is a medical device company based in Seattle, Washington, focused on developing and commercializing innovative products for wound closure and care. The company's flagship product, microMend, features a unique design that incorporates tiny Microstaples on an adhesive backing, resembling a butterfly bandage. This product is painless to apply and offers the holding strength of traditional sutures, making it suitable for closing surgical incisions and lacerations. Clinical studies indicate that microMend outperforms sutures in various clinical outcomes, including cosmetic results, and can be applied more quickly by a range of medical personnel, resulting in significant cost savings. microMend is marketed across numerous surgical specialties, as well as in dermatology and emergency medicine, with additional commercialization efforts targeting military applications. The potential market for microMend is substantial, estimated at over $600 million in the U.S. and around $2 billion globally. KitoTech Medical was founded in 2011.

CurvaFix, Inc. is a medical device company based in Bellevue, Washington, founded in 2017. The company focuses on developing innovative solutions for orthopedic trauma, specifically targeting pelvic fractures. Its flagship product, The CurvaFix, is an intramedullary rod screw designed to conform to the natural curvature of bones, effectively filling the space within curved structures such as the pelvis. By enabling surgeons to perform simpler and shorter procedures, CurvaFix aims to enhance patient recovery outcomes in the treatment of pelvic injuries.

LumiThera, Inc. is a medical device company dedicated to developing innovative treatment solutions aimed at improving visual function and preventing vision loss associated with debilitating eye diseases. Founded in 2013 and based in Poulsbo, Washington, the company specializes in photobiomodulation therapy, utilizing non-invasive light-emitting diodes (LEDs) and laser treatments to address both acute and chronic ocular disorders. Its flagship product, The Valeda, is designed specifically for the treatment of dry age-related macular degeneration (AMD) and other ocular conditions. LumiThera's technology not only strives to halt or slow the progression of vision-threatening diseases but also aims to enhance visual acuity and contrast sensitivity in patients. Through its advancements in light therapy, LumiThera supports healthcare providers in offering improved treatment options for individuals affected by these common eye disorders.

Kineta, Inc. is a clinical stage biotechnology company based in Seattle, Washington, focused on the development of immunology-based therapeutics for oncology, neuroscience, and virology. The company is advancing a range of innovative therapies, including KCP-506, a non-opioid antagonist for chronic pain, and LHF-535, an oral antiviral targeting Lassa and other arenaviruses by inhibiting viral entry and replication. Kineta is also engaged in developing next-generation immunotherapies, exemplified by KVA12.1, a VISTA blocking immunotherapy designed to reprogram the immune system to combat cancer. With strategic partnerships with notable organizations like Pfizer and Genentech, Kineta aims to leverage its expertise in antiviral therapies and immune modulation to address significant medical challenges. Formerly known as Lecura, Inc., the company was founded in 2007.

StormSensor, Inc. is a company based in Seattle, Washington, that specializes in stormwater management solutions aimed at tracking and preventing flooding, sewage overflows, and other stormwater issues. Founded in 2015, it develops Scute sensors that provide real-time monitoring of stormwater systems. Additionally, StormSensor offers Terrapin, a cloud-based software platform that allows users to visualize data on maps and time-series, correlate it with real-time weather information, and receive alerts for significant flow events. This system automates workflow for inspections, data monitoring, and regulatory reporting, thereby helping clients streamline compliance processes in a complex regulatory environment. By providing critical insights into urban flooding, illicit discharges, and the impacts of climate change, StormSensor enables its clients to respond effectively to climate-driven risks and make informed decisions regarding infrastructure maintenance and improvements.

Inmedix, LLC is a company focused on developing diagnostics and therapeutics for autoimmune diseases by assessing and optimizing the autonomic nervous system's (ANS) control of stress responses in the brain. Founded in 2006 and located in Normandy Park, Washington, Inmedix has introduced a novel class of diagnostics and therapeutics aimed at understanding the relationship between ANS stress and autoimmune conditions. This approach, termed Immuno-autonomics, seeks to mitigate the exacerbating effects of stress on autoimmune diseases, enhancing the efficacy of existing therapies. Inmedix offers a cloud-based software platform along with diagnostic devices that track the interaction between stress and immune function, providing valuable insights for clinicians and opportunities in drug discovery.

HaptX develops advanced virtual reality gloves that simulate touch sensation with remarkable realism. By utilizing patented microfluidic technology, HaptX Gloves offer 130 points of touch feedback and provide resistive force feedback of 4 lbs. per finger while tracking hand motions with sub-millimeter precision. This innovative device creates a haptic experience that allows users to perceive the texture, shape, motion, vibration, and temperature of virtual objects, enhancing interaction within the virtual environment. Founded by Jake Rubin and Dr. Bob Crockett, HaptX operates with a team of 35 employees across offices in Seattle, Washington, and San Luis Obispo, California.

HaptX develops advanced virtual reality gloves that simulate touch sensation with remarkable realism. By utilizing patented microfluidic technology, HaptX Gloves offer 130 points of touch feedback and provide resistive force feedback of 4 lbs. per finger while tracking hand motions with sub-millimeter precision. This innovative device creates a haptic experience that allows users to perceive the texture, shape, motion, vibration, and temperature of virtual objects, enhancing interaction within the virtual environment. Founded by Jake Rubin and Dr. Bob Crockett, HaptX operates with a team of 35 employees across offices in Seattle, Washington, and San Luis Obispo, California.

Varidi, Inc. is a company that specializes in a cloud-based payment platform aimed at helping businesses offer flexible financing options directly to consumers. Founded in 2013 and headquartered in Woodinville, Washington, Varidi's platform provides a comprehensive suite of payment and cash flow solutions, allowing businesses to streamline payment processes through e-invoicing, pay-now, and pay-overtime options. This system not only simplifies the management of payment plans with automated invoicing but also reduces administrative burdens, thereby lowering overhead costs and minimizing bad debt. By enabling businesses to offer diverse payment options, Varidi supports increased revenue generation and customer loyalty.

Joule Case, Inc. designs and manufactures innovative battery and solar modules, providing scalable energy solutions that prioritize mobility and sustainability. Founded in 2015 and based in Seattle, Washington, the company offers a range of products, including various control and battery modules, which cater to diverse applications such as live events, electric vehicle fleet extension, construction sites, and portable food and beverage services. Joule Case's systems are engineered to integrate seamlessly with renewable energy sources, enabling users to minimize emissions and overcome traditional energy infrastructure limitations. The company's offerings promote a quieter, more efficient alternative to conventional gas generators while enhancing energy storage capabilities and adaptability to specific power needs.

Monitor Mask Inc. is a medical device company based in Seattle, Washington, that specializes in manufacturing and selling face mask solutions for CO2 sampling in sidestream capnography during sedation anesthesia. Founded in 2012, the company primarily serves hospitals, ambulatory surgery centers, operating rooms, emergency departments, post-anesthesia care units, intensive care units, emergency medical services, and catheterization laboratories. Its flagship product, the M1 Capnography Mask, inspired the CapnoVue face mask series, which is designed to enhance patient safety by monitoring carbon dioxide levels in a patient's breath. The masks feature pre-formed ports that allow for accurate assessment of oxygen supply, thereby enabling clinicians to improve patient safety and streamline care workflows. Monitor Mask operates as a subsidiary of Salter Labs Inc.

Teadora, LLC is a manufacturer of natural personal care products based in Bellevue, Washington, founded in 2015. The company specializes in crafting a distinctive line of body, hair, and skincare items made from natural and organic superfruits known for their anti-aging properties. Teadora's product range includes cleansers, shampoos, conditioners, exfoliating and tonic bars, and moisturizing oils, all formulated with sustainable, antioxidant-rich ingredients sourced from the rainforest. These products aim to promote skin health and address various skin-related concerns. Teadora sells its offerings primarily through online channels, focusing on providing consumers with effective and environmentally conscious beauty and wellness solutions.

Kineta, Inc. is a clinical stage biotechnology company based in Seattle, Washington, focused on the development of immunology-based therapeutics for oncology, neuroscience, and virology. The company is advancing a range of innovative therapies, including KCP-506, a non-opioid antagonist for chronic pain, and LHF-535, an oral antiviral targeting Lassa and other arenaviruses by inhibiting viral entry and replication. Kineta is also engaged in developing next-generation immunotherapies, exemplified by KVA12.1, a VISTA blocking immunotherapy designed to reprogram the immune system to combat cancer. With strategic partnerships with notable organizations like Pfizer and Genentech, Kineta aims to leverage its expertise in antiviral therapies and immune modulation to address significant medical challenges. Formerly known as Lecura, Inc., the company was founded in 2007.

CurvaFix, Inc. is a medical device company based in Bellevue, Washington, founded in 2017. The company focuses on developing innovative solutions for orthopedic trauma, specifically targeting pelvic fractures. Its flagship product, The CurvaFix, is an intramedullary rod screw designed to conform to the natural curvature of bones, effectively filling the space within curved structures such as the pelvis. By enabling surgeons to perform simpler and shorter procedures, CurvaFix aims to enhance patient recovery outcomes in the treatment of pelvic injuries.

ActX, Inc. is a company based in Seattle, Washington, founded in 2012, that specializes in integrating genomic information into clinical practice. The company focuses on providing actionable clinical insights derived from patients' genetic data, which helps healthcare providers personalize medical care. ActX offers services that include the collection and analysis of saliva samples, ensuring that genetic information is securely stored and privately managed. This enables physicians to access relevant genomic insights either through electronic medical records or a secure online platform, thereby enhancing patient care and improving health outcomes.

OtoNexus Medical Technologies Inc. specializes in the design, development, and commercialization of a patented ultrasound medical device aimed at diagnosing middle ear infections, also known as otitis media, in both children and adults. This innovative device provides clinicians with the ability to differentiate between viral and bacterial infections, facilitating informed decisions regarding the necessity of antibiotics. By employing ultrasound technology in a novel manner, the device delivers rapid diagnosis in seconds and can be utilized by various healthcare professionals, including physicians and non-physician personnel. Additionally, the incorporation of one-use-per-patient tips generates a recurring revenue stream for the company. Founded in 2010 and based in Seattle, Washington, OtoNexus Medical Technologies was previously known as OtoMetrix Medical Technologies before rebranding in July 2014.

Pattern Computer, Inc. is a pattern discovery company based in Friday Harbor, Washington, that specializes in uncovering insights from complex datasets. Founded in 2016, the company has developed a proprietary system that generates hypotheses and insights, enabling clients to tackle challenging problems in fields such as medical research and business analytics. Its platform is particularly noted for its application in breast cancer prognostics and the differentiation of healthy and disease-state pathways in microbiome and human gut disorders. By utilizing advanced techniques that surpass conventional methods, Pattern Computer aims to reveal novel patterns that can drive innovation and improve industry standards.

Pathware Inc. specializes in developing automated point-of-care biopsy assessment systems aimed at enhancing the diagnostic capabilities of clinicians and pathologists. Its flagship product, Bioptic, allows for the rapid diagnosis of pathogens, while its sample management platform streamlines the pathology workflow by minimizing repetitive tasks. The company’s digital pathology platform integrates advanced hardware and software tools, facilitating immediate analysis of tissue samples at the point of care, thereby reducing the need to send samples to central laboratories. This innovation significantly shortens turnaround times and improves patient care through AI-powered image analysis and telepathology capabilities. Founded in 2017 and headquartered in Ann Arbor, Michigan, with an additional location in Seattle, Washington, Pathware is dedicated to improving healthcare by leveraging computational microscopy and artificial intelligence for more accurate and timely disease diagnosis and treatment.

Healionics Corporation, founded in 2007 and based in Seattle, Washington, specializes in the development and manufacturing of synthetic biomaterials and implantable medical devices aimed at improving healthcare for kidney failure patients. The company has created STARport HD, an implantable device that enables needle-free access to the bloodstream for hemodialysis, and STARgraft, a synthetic vascular graft designed to maintain long-term blood flow without frequent interventions. Healionics' innovations address critical challenges in dialysis treatment, particularly the unreliability of current vascular access methods, which can lead to costly complications. Their STAR biomaterial technology enhances the performance of medical implants by reducing infection and scar tissue formation. Healionics is preparing to initiate human studies for its products, with a focus on improving patient outcomes and reducing overall treatment costs in the dialysis sector.

Kineta, Inc. is a clinical stage biotechnology company based in Seattle, Washington, focused on the development of immunology-based therapeutics for oncology, neuroscience, and virology. The company is advancing a range of innovative therapies, including KCP-506, a non-opioid antagonist for chronic pain, and LHF-535, an oral antiviral targeting Lassa and other arenaviruses by inhibiting viral entry and replication. Kineta is also engaged in developing next-generation immunotherapies, exemplified by KVA12.1, a VISTA blocking immunotherapy designed to reprogram the immune system to combat cancer. With strategic partnerships with notable organizations like Pfizer and Genentech, Kineta aims to leverage its expertise in antiviral therapies and immune modulation to address significant medical challenges. Formerly known as Lecura, Inc., the company was founded in 2007.

HaptX develops advanced virtual reality gloves that simulate touch sensation with remarkable realism. By utilizing patented microfluidic technology, HaptX Gloves offer 130 points of touch feedback and provide resistive force feedback of 4 lbs. per finger while tracking hand motions with sub-millimeter precision. This innovative device creates a haptic experience that allows users to perceive the texture, shape, motion, vibration, and temperature of virtual objects, enhancing interaction within the virtual environment. Founded by Jake Rubin and Dr. Bob Crockett, HaptX operates with a team of 35 employees across offices in Seattle, Washington, and San Luis Obispo, California.

Varidi, Inc. is a company that specializes in a cloud-based payment platform aimed at helping businesses offer flexible financing options directly to consumers. Founded in 2013 and headquartered in Woodinville, Washington, Varidi's platform provides a comprehensive suite of payment and cash flow solutions, allowing businesses to streamline payment processes through e-invoicing, pay-now, and pay-overtime options. This system not only simplifies the management of payment plans with automated invoicing but also reduces administrative burdens, thereby lowering overhead costs and minimizing bad debt. By enabling businesses to offer diverse payment options, Varidi supports increased revenue generation and customer loyalty.

ActX, Inc. is a company based in Seattle, Washington, founded in 2012, that specializes in integrating genomic information into clinical practice. The company focuses on providing actionable clinical insights derived from patients' genetic data, which helps healthcare providers personalize medical care. ActX offers services that include the collection and analysis of saliva samples, ensuring that genetic information is securely stored and privately managed. This enables physicians to access relevant genomic insights either through electronic medical records or a secure online platform, thereby enhancing patient care and improving health outcomes.

CurvaFix, Inc. is a medical device company based in Bellevue, Washington, founded in 2017. The company focuses on developing innovative solutions for orthopedic trauma, specifically targeting pelvic fractures. Its flagship product, The CurvaFix, is an intramedullary rod screw designed to conform to the natural curvature of bones, effectively filling the space within curved structures such as the pelvis. By enabling surgeons to perform simpler and shorter procedures, CurvaFix aims to enhance patient recovery outcomes in the treatment of pelvic injuries.

Beta Hatch Inc. specializes in the production of insect protein primarily for animal feed, utilizing innovative rearing technology that converts organic waste into nutritious insect protein, oils, and fertilizers. The company focuses on farming mealworms and produces insect manure, or frass, as a by-product for use in fertilizers. Additionally, Beta Hatch transforms spent brewery grains into insect feed, contributing to a sustainable and zero-waste agricultural system. With a commitment to advancing food systems, the company also explores potential applications for insect exoskeletons in bioplastics and pharmaceuticals. Founded in 2015 and based in Cashmere, Washington, Beta Hatch serves a diverse clientele that includes farmers, ranchers, and researchers, aiming to establish insects as a valuable commodity crop in the agricultural landscape.

Tech Traks is a company based in Washington, USA, that specializes in digital security enhancements for identification badges. The company develops access control devices designed to help employees monitor their ID badges effectively. Utilizing magnetic attachments, audible alerts, and Bluetooth Low Energy mesh networking, Tech Traks' devices provide real-time location tracking. This technology notifies employees if their ID badge is separated from the device, enabling clients to locate lost badges and potentially disable access cards to enhance facility security.

OtoNexus Medical Technologies Inc. specializes in the design, development, and commercialization of a patented ultrasound medical device aimed at diagnosing middle ear infections, also known as otitis media, in both children and adults. This innovative device provides clinicians with the ability to differentiate between viral and bacterial infections, facilitating informed decisions regarding the necessity of antibiotics. By employing ultrasound technology in a novel manner, the device delivers rapid diagnosis in seconds and can be utilized by various healthcare professionals, including physicians and non-physician personnel. Additionally, the incorporation of one-use-per-patient tips generates a recurring revenue stream for the company. Founded in 2010 and based in Seattle, Washington, OtoNexus Medical Technologies was previously known as OtoMetrix Medical Technologies before rebranding in July 2014.

LumiThera, Inc. is a medical device company dedicated to developing innovative treatment solutions aimed at improving visual function and preventing vision loss associated with debilitating eye diseases. Founded in 2013 and based in Poulsbo, Washington, the company specializes in photobiomodulation therapy, utilizing non-invasive light-emitting diodes (LEDs) and laser treatments to address both acute and chronic ocular disorders. Its flagship product, The Valeda, is designed specifically for the treatment of dry age-related macular degeneration (AMD) and other ocular conditions. LumiThera's technology not only strives to halt or slow the progression of vision-threatening diseases but also aims to enhance visual acuity and contrast sensitivity in patients. Through its advancements in light therapy, LumiThera supports healthcare providers in offering improved treatment options for individuals affected by these common eye disorders.

Blaze Bioscience, Inc. is a biotechnology company based in Seattle, Washington, focused on developing innovative products to assist surgeons in treating cancer patients. The company specializes in tumor paint technology, which enhances real-time visualization of cancer cells during surgery. Its lead product candidate, BLZ-100, combines a targeting peptide with a fluorescent dye that emits near-infrared light, facilitating the identification and precise resection of tumors across various solid tumor types, including brain, breast, prostate, lung, colorectal, skin, and sarcoma cancers. Founded in 2010, Blaze Bioscience aims to improve surgical outcomes by enabling better detection of cancerous tissues while preserving surrounding healthy tissue.

Monitor Mask Inc. is a medical device company based in Seattle, Washington, that specializes in manufacturing and selling face mask solutions for CO2 sampling in sidestream capnography during sedation anesthesia. Founded in 2012, the company primarily serves hospitals, ambulatory surgery centers, operating rooms, emergency departments, post-anesthesia care units, intensive care units, emergency medical services, and catheterization laboratories. Its flagship product, the M1 Capnography Mask, inspired the CapnoVue face mask series, which is designed to enhance patient safety by monitoring carbon dioxide levels in a patient's breath. The masks feature pre-formed ports that allow for accurate assessment of oxygen supply, thereby enabling clinicians to improve patient safety and streamline care workflows. Monitor Mask operates as a subsidiary of Salter Labs Inc.

Kineta, Inc. is a clinical stage biotechnology company based in Seattle, Washington, focused on the development of immunology-based therapeutics for oncology, neuroscience, and virology. The company is advancing a range of innovative therapies, including KCP-506, a non-opioid antagonist for chronic pain, and LHF-535, an oral antiviral targeting Lassa and other arenaviruses by inhibiting viral entry and replication. Kineta is also engaged in developing next-generation immunotherapies, exemplified by KVA12.1, a VISTA blocking immunotherapy designed to reprogram the immune system to combat cancer. With strategic partnerships with notable organizations like Pfizer and Genentech, Kineta aims to leverage its expertise in antiviral therapies and immune modulation to address significant medical challenges. Formerly known as Lecura, Inc., the company was founded in 2007.

Textile-Based Delivery, Inc., operating under the name Nufabrx, specializes in the development and manufacturing of fabrics embedded with medications and therapeutic substances. The company offers a range of products, including bamboo pillowcases infused with tea tree oil and lavender that release these ingredients during sleep. Its innovative approach extends to various textile applications, such as headbands, wristbands, socks, shirts, shorts, underwear, shoes, leggings, athletic apparel, and swimwear. Nufabrx utilizes five patent-pending technologies that facilitate the secure and controlled release of essential oils, vitamins, and cosmeceuticals over extended periods, even enduring numerous laundering cycles. Founded in 2011, the company is headquartered in Seattle, Washington, with an additional office in Minneapolis, Minnesota.

Joylux, Inc. is a health and wellness company based in Seattle, Washington, specializing in women's health solutions. Founded in 2013, the company develops LED-focused medical devices aimed at addressing pelvic-floor issues and enhancing vaginal health. Joylux offers an at-home pelvic-floor toning and vaginal rejuvenation device that employs photobiomodulation technology to alleviate symptoms associated with genitourinary syndrome of menopause. The company is dedicated to providing noninvasive, effective, and affordable products that improve various aspects of women's intimate health, while also focusing on collecting health data to help women better predict and manage their symptoms during menopause.

Phytelligence, Inc. is an agricultural biotechnology company that specializes in growing and providing high-quality plants and innovative solutions for growers, nurseries, and horticultural experts. Founded in 2012 and based in Pullman, Washington, the company offers a range of tissue-cultured plantlets, including varieties of pear, apple, cherry, grape, and strawberry, all free from diseases, viruses, and pests. Phytelligence also provides custom genetic analysis services to evaluate the genetic similarities and differences among closely related plant samples. Its advanced propagation and quality control processes ensure that clients receive genetically confirmed plants that are healthy and ready for planting, ultimately enhancing productivity and quality in crop production.

OtoNexus Medical Technologies Inc. specializes in the design, development, and commercialization of a patented ultrasound medical device aimed at diagnosing middle ear infections, also known as otitis media, in both children and adults. This innovative device provides clinicians with the ability to differentiate between viral and bacterial infections, facilitating informed decisions regarding the necessity of antibiotics. By employing ultrasound technology in a novel manner, the device delivers rapid diagnosis in seconds and can be utilized by various healthcare professionals, including physicians and non-physician personnel. Additionally, the incorporation of one-use-per-patient tips generates a recurring revenue stream for the company. Founded in 2010 and based in Seattle, Washington, OtoNexus Medical Technologies was previously known as OtoMetrix Medical Technologies before rebranding in July 2014.

Textile-Based Delivery, Inc., operating under the name Nufabrx, specializes in the development and manufacturing of fabrics embedded with medications and therapeutic substances. The company offers a range of products, including bamboo pillowcases infused with tea tree oil and lavender that release these ingredients during sleep. Its innovative approach extends to various textile applications, such as headbands, wristbands, socks, shirts, shorts, underwear, shoes, leggings, athletic apparel, and swimwear. Nufabrx utilizes five patent-pending technologies that facilitate the secure and controlled release of essential oils, vitamins, and cosmeceuticals over extended periods, even enduring numerous laundering cycles. Founded in 2011, the company is headquartered in Seattle, Washington, with an additional office in Minneapolis, Minnesota.

Resonance AI is a company that specializes in artificial intelligence and analytics, focusing on video content analysis. Founded in 2013 and headquartered in Seattle, Washington, the company has developed a platform that utilizes machine learning to dissect various elements of videos, including dialogue and music. This technology enables Resonance AI to provide insights into audience engagement and preferences, helping businesses understand the connection between their content and viewer behaviors. The platform is adaptable to different types of video content, such as TV shows, trailers, and advertisements, allowing companies to make informed decisions that can enhance viewer engagement, subscriptions, and sales.

Precision Image Analysis, Inc., based in Kirkland, Washington, specializes in cloud-based remote medical image post-processing and analysis services for diagnostic medical studies, particularly in CT and MRI imaging. Founded in 2012, the company serves healthcare institutions, universities, and research organizations, providing timely analysis that can be delivered in as little as two hours. Its HIPAA-compliant platform allows users to upload images and monitor their analyses remotely, ensuring efficient workflow and standardized reporting. Precision Image Analysis offers particular expertise in cardiac, vascular, and neuro imaging, allowing healthcare providers to manage image analysis tasks without the need for additional staffing or extensive training on new technology. This capability enables clients to scale their image analysis efforts flexibly and cost-effectively, addressing fluctuations in demand without compromising on quality or efficiency.

Kineta, Inc. is a clinical stage biotechnology company based in Seattle, Washington, focused on the development of immunology-based therapeutics for oncology, neuroscience, and virology. The company is advancing a range of innovative therapies, including KCP-506, a non-opioid antagonist for chronic pain, and LHF-535, an oral antiviral targeting Lassa and other arenaviruses by inhibiting viral entry and replication. Kineta is also engaged in developing next-generation immunotherapies, exemplified by KVA12.1, a VISTA blocking immunotherapy designed to reprogram the immune system to combat cancer. With strategic partnerships with notable organizations like Pfizer and Genentech, Kineta aims to leverage its expertise in antiviral therapies and immune modulation to address significant medical challenges. Formerly known as Lecura, Inc., the company was founded in 2007.

Blaze Bioscience, Inc. is a biotechnology company based in Seattle, Washington, focused on developing innovative products to assist surgeons in treating cancer patients. The company specializes in tumor paint technology, which enhances real-time visualization of cancer cells during surgery. Its lead product candidate, BLZ-100, combines a targeting peptide with a fluorescent dye that emits near-infrared light, facilitating the identification and precise resection of tumors across various solid tumor types, including brain, breast, prostate, lung, colorectal, skin, and sarcoma cancers. Founded in 2010, Blaze Bioscience aims to improve surgical outcomes by enabling better detection of cancerous tissues while preserving surrounding healthy tissue.

LumiThera, Inc. is a medical device company dedicated to developing innovative treatment solutions aimed at improving visual function and preventing vision loss associated with debilitating eye diseases. Founded in 2013 and based in Poulsbo, Washington, the company specializes in photobiomodulation therapy, utilizing non-invasive light-emitting diodes (LEDs) and laser treatments to address both acute and chronic ocular disorders. Its flagship product, The Valeda, is designed specifically for the treatment of dry age-related macular degeneration (AMD) and other ocular conditions. LumiThera's technology not only strives to halt or slow the progression of vision-threatening diseases but also aims to enhance visual acuity and contrast sensitivity in patients. Through its advancements in light therapy, LumiThera supports healthcare providers in offering improved treatment options for individuals affected by these common eye disorders.

Monitor Mask Inc. is a medical device company based in Seattle, Washington, that specializes in manufacturing and selling face mask solutions for CO2 sampling in sidestream capnography during sedation anesthesia. Founded in 2012, the company primarily serves hospitals, ambulatory surgery centers, operating rooms, emergency departments, post-anesthesia care units, intensive care units, emergency medical services, and catheterization laboratories. Its flagship product, the M1 Capnography Mask, inspired the CapnoVue face mask series, which is designed to enhance patient safety by monitoring carbon dioxide levels in a patient's breath. The masks feature pre-formed ports that allow for accurate assessment of oxygen supply, thereby enabling clinicians to improve patient safety and streamline care workflows. Monitor Mask operates as a subsidiary of Salter Labs Inc.

Precision Image Analysis, Inc., based in Kirkland, Washington, specializes in cloud-based remote medical image post-processing and analysis services for diagnostic medical studies, particularly in CT and MRI imaging. Founded in 2012, the company serves healthcare institutions, universities, and research organizations, providing timely analysis that can be delivered in as little as two hours. Its HIPAA-compliant platform allows users to upload images and monitor their analyses remotely, ensuring efficient workflow and standardized reporting. Precision Image Analysis offers particular expertise in cardiac, vascular, and neuro imaging, allowing healthcare providers to manage image analysis tasks without the need for additional staffing or extensive training on new technology. This capability enables clients to scale their image analysis efforts flexibly and cost-effectively, addressing fluctuations in demand without compromising on quality or efficiency.

KPI Therapeutics, Inc. is a biotechnology company specializing in the development of therapies for unmet medical needs, particularly in the fields of autoimmunity and chronic pain. The company offers several drug candidates, including dalazatide, KPI-150, and KPI-190, targeting systemic autoimmune diseases such as lupus, as well as a CSP conopeptide aimed at managing chronic pain. Founded in 2013 and based in Seattle, Washington, KPI Therapeutics collaborates with various partners, including Kineta, Inc., Chimera Biotec, and the University of Washington School of Medicine, to enhance drug development and improve access to new treatments. The company is committed to accelerating the progression of promising drug candidates through critical stages of development, addressing significant gaps in patient care.

Tilting Motor Works, Inc. specializes in developing leaning three-wheel conversion solutions for motorcycles, enhancing their stability and safety without compromising performance. Founded in 2008 and headquartered in Snohomish, Washington, the company replaces the front fork and wheel of traditional motorcycles with a new front end that integrates various components, including shocks, wheels, tires, brakes, and hydraulic systems. This patented retrofit aims to provide riders with an improved riding experience by offering higher performance and increased confidence on the road. With a focus on safety and stability, Tilting Motor Works continues to innovate in the motorcycle modification industry.

Monitor Mask Inc. is a medical device company based in Seattle, Washington, that specializes in manufacturing and selling face mask solutions for CO2 sampling in sidestream capnography during sedation anesthesia. Founded in 2012, the company primarily serves hospitals, ambulatory surgery centers, operating rooms, emergency departments, post-anesthesia care units, intensive care units, emergency medical services, and catheterization laboratories. Its flagship product, the M1 Capnography Mask, inspired the CapnoVue face mask series, which is designed to enhance patient safety by monitoring carbon dioxide levels in a patient's breath. The masks feature pre-formed ports that allow for accurate assessment of oxygen supply, thereby enabling clinicians to improve patient safety and streamline care workflows. Monitor Mask operates as a subsidiary of Salter Labs Inc.

LumiThera, Inc. is a medical device company dedicated to developing innovative treatment solutions aimed at improving visual function and preventing vision loss associated with debilitating eye diseases. Founded in 2013 and based in Poulsbo, Washington, the company specializes in photobiomodulation therapy, utilizing non-invasive light-emitting diodes (LEDs) and laser treatments to address both acute and chronic ocular disorders. Its flagship product, The Valeda, is designed specifically for the treatment of dry age-related macular degeneration (AMD) and other ocular conditions. LumiThera's technology not only strives to halt or slow the progression of vision-threatening diseases but also aims to enhance visual acuity and contrast sensitivity in patients. Through its advancements in light therapy, LumiThera supports healthcare providers in offering improved treatment options for individuals affected by these common eye disorders.

Precision Image Analysis, Inc., based in Kirkland, Washington, specializes in cloud-based remote medical image post-processing and analysis services for diagnostic medical studies, particularly in CT and MRI imaging. Founded in 2012, the company serves healthcare institutions, universities, and research organizations, providing timely analysis that can be delivered in as little as two hours. Its HIPAA-compliant platform allows users to upload images and monitor their analyses remotely, ensuring efficient workflow and standardized reporting. Precision Image Analysis offers particular expertise in cardiac, vascular, and neuro imaging, allowing healthcare providers to manage image analysis tasks without the need for additional staffing or extensive training on new technology. This capability enables clients to scale their image analysis efforts flexibly and cost-effectively, addressing fluctuations in demand without compromising on quality or efficiency.

Aqueduct Critical Care, founded in 2013 and based in Bothell, Washington, focuses on developing medical devices aimed at improving the management of inter-cranial pressure (ICP) in patients with neurological diseases related to cerebral spinal fluid. The company's innovative devices utilize gravity-based drainage systems to automate the regulation of ICP, reducing the need for constant manual monitoring and adjustments. This advancement not only enhances patient mobility but also allows hospital staff to conduct necessary tests and physical therapy with minimal intervention, thereby optimizing care and reducing the demands on nursing resources.

OtoNexus Medical Technologies Inc. specializes in the design, development, and commercialization of a patented ultrasound medical device aimed at diagnosing middle ear infections, also known as otitis media, in both children and adults. This innovative device provides clinicians with the ability to differentiate between viral and bacterial infections, facilitating informed decisions regarding the necessity of antibiotics. By employing ultrasound technology in a novel manner, the device delivers rapid diagnosis in seconds and can be utilized by various healthcare professionals, including physicians and non-physician personnel. Additionally, the incorporation of one-use-per-patient tips generates a recurring revenue stream for the company. Founded in 2010 and based in Seattle, Washington, OtoNexus Medical Technologies was previously known as OtoMetrix Medical Technologies before rebranding in July 2014.

KPI Therapeutics, Inc. is a biotechnology company specializing in the development of therapies for unmet medical needs, particularly in the fields of autoimmunity and chronic pain. The company offers several drug candidates, including dalazatide, KPI-150, and KPI-190, targeting systemic autoimmune diseases such as lupus, as well as a CSP conopeptide aimed at managing chronic pain. Founded in 2013 and based in Seattle, Washington, KPI Therapeutics collaborates with various partners, including Kineta, Inc., Chimera Biotec, and the University of Washington School of Medicine, to enhance drug development and improve access to new treatments. The company is committed to accelerating the progression of promising drug candidates through critical stages of development, addressing significant gaps in patient care.

Kineta, Inc. is a clinical stage biotechnology company based in Seattle, Washington, focused on the development of immunology-based therapeutics for oncology, neuroscience, and virology. The company is advancing a range of innovative therapies, including KCP-506, a non-opioid antagonist for chronic pain, and LHF-535, an oral antiviral targeting Lassa and other arenaviruses by inhibiting viral entry and replication. Kineta is also engaged in developing next-generation immunotherapies, exemplified by KVA12.1, a VISTA blocking immunotherapy designed to reprogram the immune system to combat cancer. With strategic partnerships with notable organizations like Pfizer and Genentech, Kineta aims to leverage its expertise in antiviral therapies and immune modulation to address significant medical challenges. Formerly known as Lecura, Inc., the company was founded in 2007.

Precision Image Analysis, Inc., based in Kirkland, Washington, specializes in cloud-based remote medical image post-processing and analysis services for diagnostic medical studies, particularly in CT and MRI imaging. Founded in 2012, the company serves healthcare institutions, universities, and research organizations, providing timely analysis that can be delivered in as little as two hours. Its HIPAA-compliant platform allows users to upload images and monitor their analyses remotely, ensuring efficient workflow and standardized reporting. Precision Image Analysis offers particular expertise in cardiac, vascular, and neuro imaging, allowing healthcare providers to manage image analysis tasks without the need for additional staffing or extensive training on new technology. This capability enables clients to scale their image analysis efforts flexibly and cost-effectively, addressing fluctuations in demand without compromising on quality or efficiency.